Kevin Mcnamara Sells 2,000 Shares of Chemed (NYSE:CHE) Stock

Chemed Corporation (NYSE:CHE) CEO Kevin Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $541.16, for a total value of $1,082,320.00. Following the completion of the sale, the chief executive officer directly owned 70,418 shares of the company’s stock, valued at approximately $38,107,404.88. This trade represents a 2.76% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Chemed Price Performance

Shares of CHE opened at $543.56 on Wednesday. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $557.00. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89. The company has a market capitalization of $7.10 billion, a price-to-earnings ratio of 27.30, a P/E/G ratio of 2.05 and a beta of 0.51. The business’s 50-day moving average is $503.79 and its 200-day moving average is $447.97.

Chemed (NYSE:CHE) last issued its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. The company had revenue of $673.25 million during the quarter, compared to analyst estimates of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter last year, the business posted $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Equities research analysts expect that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be paid a $0.70 dividend. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend is Monday, August 17th. This is a positive change from Chemed’s previous quarterly dividend of $0.60. Chemed’s dividend payout ratio (DPR) is presently 14.06%.

Hedge Funds Weigh In On Chemed

A number of institutional investors have recently made changes to their positions in the business. California State Teachers Retirement System boosted its stake in Chemed by 45,134.8% during the 2nd quarter. California State Teachers Retirement System now owns 7,613,918 shares of the company’s stock valued at $3,546,106,000 after purchasing an additional 7,597,086 shares during the period. Northwestern Mutual Wealth Management Co. grew its holdings in Chemed by 2,444,879.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock valued at $2,374,667,000 after buying an additional 5,549,876 shares during the last quarter. BlackRock Inc. bought a new position in Chemed in the 2nd quarter worth approximately $691,290,000. Norges Bank bought a new position in Chemed in the 4th quarter worth approximately $76,067,000. Finally, AQR Capital Management LLC lifted its holdings in shares of Chemed by 89.2% during the fourth quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock worth $139,302,000 after buying an additional 153,469 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research firms have issued reports on CHE. Oppenheimer lifted their target price on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research note on Friday, July 31st. Bank of America restated a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Finally, Royal Bank Of Canada upped their price objective on shares of Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a report on Thursday, July 30th. One research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $530.75.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.